...
首页> 外文期刊>Acta Poloniae Pharmaceutica: Durg Research >RNA-HCV viral load in serum, peripheral blood mononuclear cells and liver in children with chronic hepatitis C
【24h】

RNA-HCV viral load in serum, peripheral blood mononuclear cells and liver in children with chronic hepatitis C

机译:慢性丙型肝炎患儿血清,外周血单个核细胞和肝脏中RNA-HCV病毒载量

获取原文
获取原文并翻译 | 示例
           

摘要

The liver is the major site of hepatitis C virus (HCV) infection and replication. However, HCV may infect and replicate in extrahepatic sites as well. Several investigators have demonstrated that peripheral blood mononuclear cells (PBMCs) are the major extrahepatic milieu of infection and viral replication. The aim of the study was to investigate the correlation between RNA-HCV level in serum, PBMCs and liver in children with chronic viral hepatitis C (CHC). The impact of RNA-HCV level on the sustained virological response (SVR) after therapy was also determined. Study was carried out in the group of 10 children with CHC, age 8 to 17 years. Antiviral therapy was implemented in all patients with pegylated interferon α (Peg-IFNα) 2a or 2b and ribavirin during 48 weeks. The following tests were performed prior the therapy: basic laboratory parameters, histology of liver biopsy, RNA-HCV viral load in serum, PBMCs and in liver. The behavior of HCV-RNA viral load in serum, PBMCs and liver in children with CHC did not present strict mutual relations. However, the positive correlation between serum and PBMCs viral load (r = 0.47) and negative correlation between PBMCs and liver viral load (r = -0,47) was demonstrated. Although no statistically significant results were found, some trends of relationship in viral load between various body compartments were present. Given the aforementioned results, it is clear that more data are needed, mostly more numerous groups of patients, especially those whose influence of RNA-HCV viral load had a major impact on the antiviral treatment.
机译:肝脏是丙型肝炎病毒(HCV)感染和复制的主要部位。但是,HCV也可能在肝外部位感染并复制。几位研究人员证明,外周血单核细胞(PBMC)是感染和病毒复制的主要肝外环境。这项研究的目的是调查慢性丙型肝炎(CHC)患儿血清,PBMC和肝脏中RNA-HCV水平的相关性。还确定了RNA-HCV水平对治疗后持续病毒学应答(SVR)的影响。在10例8至17岁的CHC儿童中进行了研究。在48周内,所有聚乙二醇化干扰素α(Peg-IFNα)2a或2b和利巴韦林的患者均进行了抗病毒治疗。在治疗之前进行了以下测试:基本实验室参数,肝活检组织学,血清,PBMC和肝中RNA-HCV病毒载量。 CHC患儿血清,PBMC和肝中HCV-RNA病毒载量的行为没有严格的相互关系。但是,血清和PBMCs病毒载量之间呈正相关(r = 0.47),而PBMCs和肝病毒载量之间呈负相关(r = -0.47)。尽管未发现统计学上显着的结果,但仍存在一些不同体室之间病毒载量之间关系的趋势。鉴于上述结果,很明显,需要更多的数据,多数是更多的患者群体,尤其是那些RNA-HCV病毒载量的影响对抗病毒治疗产生重大影响的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号